TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 12 | 20 | 7 | 53 | -49 | 0 | 9 |
| P | %wins | 100 | 100 | 100 | 100 | 0 | 80 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/3/22 21:47 | 8/1/22 | NBRV | Nabriva Therapeutics Plc | L2 | Health | Drug | Pharmaceutical Preparations | Bourdow Carrie L. | PA | D | S | -1 | 0.1741 | 0 | -9 | -46 | 10 | D | |||||||||||||||
8/4/21 21:04 | 8/2/21 | NBRV | Nabriva Therapeutics Plc | L2 | Health | Drug | Pharmaceutical Preparations | Bourdow Carrie L. | PA | D | S | -1 | 1.20 | 0 | -1 | -4 | 18 | D | |||||||||||||||
6/28/21 17:33 | 6/28/21 | TRVN | Trevena Inc | DE | Health | Drug | Pharmaceutical Preparations | Bourdow Carrie L. | PA | DO | P,CEO | P | 101 | 1.79 | 0 | 56 | 5 | 1,302 | D | ||||||||||||||
11/10/16 18:12 | 11/9/16 | TRVN | Trevena Inc | DE | Health | Drug | Pharmaceutical Preparations | Bourdow Carrie L. | PA | O | SVP,Chie | P | 17 | 4.34 | 2 | 4 | 800 | 5 | D | -23 | -58 | -35 | -34 | -32 | -23 | -7 | 11 | 12 | 20 | 7 | 53 | -49 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |